Table: Fractale -2019/20 group results

ADR Biomedical Holdings

15/05/2020 07:00

May 15 (Reuters)- 
          Fractale Corporation 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2020    Mar 31, 2019   Mar 31, 2021     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           1.18            1.92                                 
               (-38.7 pct)    (+268.6 pct)                             
  Operating   loss 129 mln       293 mln                               
                              (+124.8 pct)                             
  Recurring   loss 185 mln       204 mln                               
                               (+60.3 pct)                             
  Net
  Net            319 mln         592 mln                               
               (-46.1 pct)     (+31.7 pct)                             
  EPS           47.58 yen       88.30 yen                              
  Ann Div       10.00 yen       20.00 yen                              
  -Q2 Div          NIL             NIL                                 
  -Q4 Div       10.00 yen       20.00 yen                              
  
  NOTE - Fractale Corporation.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3750.T